About 1 200 reports

  • 1.4 Allergy Immunotherapy
  • 3. Allergy Immunotherapy Market Analysis

Global Allergy Immunotherapy Market: Industry Analysis & Outlook (2019- 2023) ##.

  • Immunotherapy
  • Respiratory Disease
  • World
  • Merck & Co., Inc.
  • Stallergenes Greer plc

The recent advances in the immunotherapy drug development are helping the pharmaceutical companies to develop more efficient immunotherapies for the treatment of various allergies.

  • Allergy Immunotherapy
  • Immunotherapy
  • Medical Biotechnology
  • World
  • Market Size
  • ALLERGIC RHINITIS IMMUNOTHERAPY: KEY METRICS IN THE 7MM
  • SALES FORECAST BY COMPANY FOR ALLERGIC RHINITIS IMMUNOTHERAPY IN THE 5EU IN 2018 AND

This means [if] a patient is sensitive toward birch and grass [they] will receive two specific immunotherapies, one with birch and one with grass.

  • Immunotherapy
  • Japan
  • United States
  • Demand
  • Torii Pharmaceutical Co., Ltd.

Precision Immunotherapy Innovations Transforming Human Health and Wellness Executive Summary ##. ## Research Background: Innovating to Address Immunotherapies ##. ## Research Scope: Emerging Immunotherapies ##. ## Analysis Framework: Frost & Sullivan Core Value ##. ## Research Met

  • Biopharmaceutical
  • Immunotherapy
  • Medical Biotechnology
  • Therapy
  • World

Global T-Cell Immunotherapy Market for Cancer & Pipeline Analysis ##.

  • Biopharmaceutical
  • Immunotherapy
  • Medical Biotechnology
  • World

Allergy Immunotherapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024 ## Preface ## Scope and Methodology ##. ## Objectives of the Study ##. ## Stakeholders ##. ## Data Sources ##. ##. ## Primary Sources ##. ##. ## Secondary Sources ##. ## Market Estimation ##. ##. ##

  • Allergy Immunotherapy
  • Immunotherapy
  • Medical Biotechnology
  • World
  • Market Size

Allergy Immunotherapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025 Chapter ## Preface ##. ##.

  • Allergy Immunotherapy
  • Immunotherapy
  • APAC
  • World
  • Market Size
  • 4.2 Pipeline by Stage of Development, Molecule Type, Route of Administration and Program Type

A prime example of this is the emergence of immunotherapies and PD-##/ PD-L## targeted agents.

  • Immunotherapy
  • Market Size
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.

Immunotherapy Drugs Market by Type, by Therapy Area, by End User, by Geography - Global Market Size, Share, Development, Growth, and Demand Forecast, 2013-2023 Chapter ##.

  • Immunotherapy
  • Medical Biotechnology
  • World
  • Demand
  • Forecast
  • 3.5.1.2. PASSIVE IMMUNOTHERAPY
  • 3.5.1.1. ACTIVE IMMUNOTHERAPY

IMMUNOTHERAPIES ARE KNOWN TO PROVIDE THERAPEUTIC BENEFITS BY ONE OF THE FOLLOWING MECHANISMS: MOREOVER, IMMUNOTHERAPY MAY PREVENT RECURRENCE OF TUMOR POST-SURGERY.

  • Immunotherapy
  • Company
  • Market Size
  • Juno Therapeutics Inc.
  • Novartis AG
  • Overview: Immunotherapy
  • Market segmentation by type of immunotherapy

Examples of immunotherapy drugs that target PD- ## include nivolumab (Opdivo) and pembrolizumab (Keytruda).

  • Immunotherapy
  • World
  • AbbVie Inc.
  • Amgen Inc.
  • Merck & Co., Inc.
  • 2.1.2 Cancer-Targeting Immunotherapies
  • Organs Functions during Immunotherapy

Hoffmann-La Roche Sales by Region; 2018 ## ##.

  • Immunotherapy
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Immunotherapy Market Revenue And Forecasts To 2027 (US$ MN)
  • North America Immunotherapy Market Revenue and Forecasts To 2027, By Type (US$ Mn)

In every one man out, seventy-nine is affected by colorectal cancer.

  • Immunotherapy
  • World
  • Forecast
  • Market Size
  • Epigenomics AG
  • 8.1.1 PEANUT IMMUNOTHERAPIES
  • 6.3.4 PEANUT DESENSITIZATION USING EXPERIMENTAL ORAL IMMUNOTHERAPY

ONE OF THE MAIN BARRIERS TO THE SUCCESS OF PEANUT IMMUNOTHERAPIES THERAPIES IS THE QUESTION OF HOW THEY WILL BE REIMBURSED.

  • Immunotherapy
  • Australia
  • World
  • Forecast
  • Aimmune Therapeutics, Inc.
  • STAGE OF DEVELOPMENT PRECLINICAL IND/CTA-FILED PHASE I PHASE II PHASE III PRE-REGISTRATION
  • Versatile Innovation in Hematological Cancers Therapeutics Market, Global, Pipeline by Stage of Development and Molecule Type,

Immunotherapy, which includes chemotherapy, has revolutionized cancer treatment.

  • Immunotherapy
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Juno Therapeutics Inc.
  • Novartis AG
  • Immunosuppressants Immunotherapies
  • GNBAC-1 OPICINUMAB

AUTOIMMUNE CONCEPTS OF MULTIPLE SCLEROSIS AS A BASIS FOR SELECTIVE IMMUNOTHERAPY: FROM PIPE DREAMS TO (THERAPEUTIC) PIPELINES.

  • Immunotherapy
  • United States
  • Forecast
  • Biogen Idec Inc.
  • Novartis AG

APPENDIX ##: TABULATED DATA ##.

  • Immunotherapy
  • Medical Biotechnology
  • Therapy
  • United States
  • Immunotherapy Drugs Sales Volume
  • Immunotherapy Drugs Sales Volume

Immunotherapy to prevent certain types of pneumonia is available.

  • Immunotherapy
  • China
  • Demand
  • Harbin Pharmaceutical Group
  • North China Pharmaceutical Group Corp.
  • Immunotherapy Drugs Sales Volume
  • Immunotherapy Drugs Sales Volume by Drugs

The auto exports exceeded over ## million each year.

  • Immunotherapy
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Changchun ChangSheng Gene Pharmaceutical Co., Ltd.
  • Immunotherapy Drugs Sales Volume
  • Immunotherapy Drugs Sales Volume by Drugs

Immunotherapy to prevent certain types of pneumonia is available.

  • Immunotherapy
  • China
  • Demand
  • Harbin Pharmaceutical Group
  • North China Pharmaceutical Group Corp.
  • Immunotherapy Drugs Sales Volume
  • Immunotherapy Drugs Sales Volume by Drugs

Immunotherapy Drugs Sales Volume α-Interferon Sales Volume ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Zhejiang Beisheng Medicine Industry Hansheng Pharmaceutical Co., Ltd.

  • Immunotherapy
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Changchun ChangSheng Gene Pharmaceutical Co., Ltd.
  • Immunotherapy Drugs Sales Volume (million Yuan)
  • Immunotherapy Drugs Sales Volume by Drugs Classification in 2018(percent)

The auto exports exceeded over ## million each year.

  • Immunotherapy
  • China
  • Demand
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Immunotherapy Drugs Sales Volume (million Yuan)
  • Immunotherapy Drugs Sales Volume by Drugs Classification in 2018(percent)

Chapter IV KIDNEY CANCER TREATMENT DRUGS PRODUCTION AND DEMAND Chart ##: Immunotherapy Drugs Sales Volume (million Yuan) The Immunotherapy Drugs contains two different kinds, and they are cytokines and cancer vaccines.

  • Immunotherapy
  • China
  • Demand
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd

Global Tumor-specific Antigen Market Chapter ## Introduction Study Goals and Objectives Reasons for Doing This Study Scope of Report Information Sources Methodology Geographic Breakdown Analyst’s Credentials Chapter ## Summary and Highlights Chapter ## Market and Technology Background Market O

  • Immunotherapy
  • Medical Biotechnology
  • Monoclonal Antibody
  • World
  • Forecast

Immunotherapy ##.

  • Immunotherapy
  • Medical Biotechnology
  • APAC
  • World
  • Market Size

Global Allergy Immunotherapy Market Analysis & Trends - Product Type(Sublingual immunotherapy drops, Subcutaneous immunotherapy and Sublingual immunotherapy tablets), Application - Forecast to 2025 ## Market Outline ##. ## Research Methodology ##. ##. ## Research Approach & Sources

  • Allergy Immunotherapy
  • Immunotherapy
  • United States
  • Forecast
  • Market Size
  • IMMUNOTHERAPIES' - PD-1 INHIBITORS UPTAKE, U.S., 2016

TOPICAL IMMUNOTHERAPY AND VASODILATORS: TOPICAL IMMUNOTHERAPY IS ONE OF THE BEST TREATMENTS SO FAR FOR SEVERE AND REFRACTORY ALOPECIA AREATA.

  • Immunotherapy
  • World
  • Forecast
  • Allergan plc
  • Galderma S.A.
  • T-cell Immunotherapy: An Introduction1
  • T-cell Immunotherapy Number of Molecules in Preclinical Development

Note on Confidentiality Contents T-cell Immunotherapy: An Introduction ## ## Market Overview Market Forecast: Scenario Comparison T-cell Immunotherapy: An Introduction## Growing Clinical Pipeline The Primary Growth Driver With no marketed products, this emerging field is still in its

  • Immunotherapy
  • Medical Biotechnology
  • United States
  • Market Size
  • Kite Pharma, Inc.
  • 7.2.3 LIMITED INCORPORATION OF IMMUNOTHERAPIES IN THE CRC TREATMENT ALGORITHM
  • 5.1.2 FAILURE RATE BY PHASE AND MOLECULE TYPE

Nivolumab as Programmed Death-## (PD-##) Inhibitor for Targeted Immunotherapy in Tumor.

  • Immunotherapy
  • Monoclonal Antibody
  • Therapy
  • Market Size
  • Merck & Co., Inc.
  • Overview: Immunotherapy
  • Market segmentation by type of immunotherapy

Examples of immunotherapy drugs that target PD- ## include nivolumab (Opdivo) and pembrolizumab (Keytruda).

  • Immunotherapy
  • World
  • AbbVie Inc.
  • Amgen Inc.
  • Merck & Co., Inc.